LU83819A1 - Derives 1-sulfo-2-oxoazetidine,leur procede de preparation et leur utilisation dans des compositions anti-microbiennes - Google Patents
Derives 1-sulfo-2-oxoazetidine,leur procede de preparation et leur utilisation dans des compositions anti-microbiennesInfo
- Publication number
- LU83819A1 LU83819A1 LU83819A LU83819A LU83819A1 LU 83819 A1 LU83819 A1 LU 83819A1 LU 83819 A LU83819 A LU 83819A LU 83819 A LU83819 A LU 83819A LU 83819 A1 LU83819 A1 LU 83819A1
- Authority
- LU
- Luxembourg
- Prior art keywords
- sulfo
- preparation
- microbial compositions
- oxoazetidine derivatives
- oxoazetidine
- Prior art date
Links
- CDFGMYLBUSYTKQ-UHFFFAOYSA-N 2-oxoazetidine-1-sulfonic acid Chemical class OS(=O)(=O)N1CCC1=O CDFGMYLBUSYTKQ-UHFFFAOYSA-N 0.000 title 1
- 230000000845 anti-microbial effect Effects 0.000 title 1
- 239000004599 antimicrobial Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
- C07D205/085—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
- C07D205/09—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4
- C07D205/095—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4 and with a nitrogen atom directly attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
- C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/10—Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/JP1980/000297 WO1982001873A1 (fr) | 1980-12-05 | 1980-12-05 | Derives 1-sulfo-2-oxoazetidine et leur procede de preparation |
PCT/JP1981/000103 WO1982003859A1 (fr) | 1980-12-05 | 1981-04-30 | Derives de 1-sulfo-2-oxoazetidine et procede de preparation |
PCT/JP1981/000183 WO1983000689A1 (fr) | 1980-12-05 | 1981-08-21 | Derives de 1-sulfo-2-oxoazetidine et leur procede de preparation |
PCT/JP1981/000252 WO1983001063A1 (fr) | 1980-12-05 | 1981-09-24 | Derives de 1-sulfo-2-oxoazetidine et leur procede de preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
LU83819A1 true LU83819A1 (fr) | 1982-05-07 |
Family
ID=27466372
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LU83819A LU83819A1 (fr) | 1980-12-05 | 1981-12-04 | Derives 1-sulfo-2-oxoazetidine,leur procede de preparation et leur utilisation dans des compositions anti-microbiennes |
Country Status (28)
Country | Link |
---|---|
US (3) | US4550105A (fr) |
EP (1) | EP0053816B1 (fr) |
AR (1) | AR240171A1 (fr) |
AT (1) | AT378768B (fr) |
AU (1) | AU557689B2 (fr) |
BE (1) | BE891366A (fr) |
BR (1) | BR8107866A (fr) |
CH (1) | CH657610A5 (fr) |
DE (2) | DE3148021A1 (fr) |
DK (1) | DK534481A (fr) |
ES (2) | ES507715A0 (fr) |
FI (1) | FI81085C (fr) |
FR (1) | FR2495613B1 (fr) |
GB (1) | GB2091724B (fr) |
GR (1) | GR77295B (fr) |
IE (1) | IE53314B1 (fr) |
IL (1) | IL64315A (fr) |
IT (1) | IT1139919B (fr) |
LU (1) | LU83819A1 (fr) |
MY (1) | MY8700314A (fr) |
NL (1) | NL8105470A (fr) |
NO (1) | NO160577C (fr) |
NZ (1) | NZ199167A (fr) |
PH (1) | PH25221A (fr) |
PT (1) | PT74088B (fr) |
SE (1) | SE457256B (fr) |
WO (5) | WO1982001873A1 (fr) |
YU (2) | YU43051B (fr) |
Families Citing this family (64)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ196202A (en) * | 1980-02-07 | 1984-07-31 | Squibb & Sons Inc | Beta-lactam antibiotics (of azetidine-sulphonic acid type) |
EP0048953B1 (fr) * | 1980-09-29 | 1988-03-09 | E.R. Squibb & Sons, Inc. | Antibiotiques de bêta-lactame |
WO1982001873A1 (fr) * | 1980-12-05 | 1982-06-10 | Takeda Chemical Industries Ltd | Derives 1-sulfo-2-oxoazetidine et leur procede de preparation |
US4675397A (en) * | 1980-12-05 | 1987-06-23 | Takeda Chemical Industries, Ltd. | 1-sulfo-2-oxoazetidine derivatives and their production |
US4673739A (en) * | 1980-12-05 | 1987-06-16 | Takeda Chemical Industries, Ltd. | 4-carbamoyloxymethyl-1-sulfo-2-oxoazetidine derivatives and their production |
US4782147A (en) * | 1980-12-05 | 1988-11-01 | Takeda Chemical Industries, Ltd. | 1-sulfo-2-oxoazetidine derivatives and their production |
US4572801A (en) * | 1981-04-30 | 1986-02-25 | Takeda Chemical Industries, Ltd. | 4-Carbamoyloxymethyl-1-sulfo-2-oxoazetidine derivatives and their production |
EP0187355A1 (fr) * | 1981-09-23 | 1986-07-16 | E.R. Squibb & Sons, Inc. | Procédé de préparation d'antibiotiques bêta-lactames |
FR2515182B1 (fr) * | 1981-10-23 | 1986-05-09 | Roussel Uclaf | Nouveaux produits derives de l'acide 3-amino 2-oxo azetidine 1-sulfamique, leur procede de preparation, leur application comme medicaments et les produits intermediaires necessaires a leur preparation |
FR2538389B2 (fr) * | 1981-10-23 | 1986-05-16 | Roussel Uclaf | Nouveaux produits derives de l'acide 3-amino 2-oxo azetidine-1-sulfamique, nouveau procede de preparation de produits optiquement actifs, application des nouveaux produits comme medicaments et produits necessaires a leur preparation |
GB2151628B (en) * | 1981-10-23 | 1986-05-21 | Roussel Uclaf | Azetidine intermediates |
FR2558467B2 (fr) * | 1981-10-23 | 1987-03-20 | Roussel Uclaf | Nouveau produit derive de l'acide 3-amino 2-oxo azetidine 1-sulfamique, son procede de preparation, son application comme medicament et un produit intermediaire necessaire a sa preparation |
IL67451A (en) * | 1981-12-25 | 1987-10-20 | Takeda Chemical Industries Ltd | 4-cyano-2-azetidinones and production thereof and process for the preparation of 4-carbamoyl-2-azetidinones using them |
AU564150B2 (en) * | 1982-04-30 | 1987-08-06 | Takeda Chemical Industries Ltd. | 1-sulfo-2-azetidinone derivatives |
JPS58210060A (ja) * | 1982-05-31 | 1983-12-07 | Takeda Chem Ind Ltd | 2−オキソアゼチジン誘導体、その製造法および用途 |
EP0096297B1 (fr) * | 1982-06-03 | 1988-06-15 | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft | Procédé de préparation de dérivés de 1-sulfo-2-oxoazétidine |
EP0096296B1 (fr) * | 1982-06-03 | 1987-07-29 | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft | Dérivés de 1-sulfo-2-oxoazétidine |
JPS5916888A (ja) * | 1982-07-20 | 1984-01-28 | Takeda Chem Ind Ltd | 1−スルホ−2−アゼチジノン誘導体およびその製造法 |
US4939253A (en) * | 1982-08-04 | 1990-07-03 | E. R. Squibb & Sons, Inc. | 2-oxoazetidin-1-yloxy acetic acids and analogs |
US4681937A (en) * | 1982-09-27 | 1987-07-21 | E. R. Squibb & Sons, Inc. | 3-acylamino-2-oxo-1-azetidinyl esters of phosphonic acids, phosphoric acid and phosphoric acid esters |
JPS5982359A (ja) * | 1982-11-02 | 1984-05-12 | Kanegafuchi Chem Ind Co Ltd | 4(R)配位光学活性β−ラクタム化合物の製法 |
US4502994A (en) * | 1982-12-09 | 1985-03-05 | Hoffmann-La Roche Inc. | Enantiomeric synthesis of 3-amino-4-carbamoyloxymethyl-2-azetidonone-1-sulfate |
FR2539128A1 (fr) * | 1983-01-10 | 1984-07-13 | Roussel Uclaf | Nouveaux derives de la 3-amino 2-oxoazetidine comportant en position 1 un radical heterocyclique azote, leur procede de preparation, leur application comme medicaments et les produits intermediaires necessaires a leur preparation |
US4652651A (en) * | 1983-05-31 | 1987-03-24 | Hoffmann-La Roche Inc. | Process for the manufacture of 1-sulpho-2-oxoazetidine carboxylic acid intermediates via catalytic ester cleavage |
US4501697A (en) * | 1983-06-17 | 1985-02-26 | E. R. Squibb & Sons, Inc. | 4-[[(Amidomethyl)oxy]methyl]-2-oxo-1-azetidinesulfonic acid salts |
US4751299A (en) * | 1983-11-18 | 1988-06-14 | Takeda Chemical Industries, Ltd. | Optically active β-lactams and method of their production |
US4680391A (en) * | 1983-12-01 | 1987-07-14 | Merck & Co., Inc. | Substituted azetidinones as anti-inflammatory and antidegenerative agents |
US4918185A (en) * | 1984-05-22 | 1990-04-17 | Eli Lilly And Company | Process for carbon-carbon bond formation at the C-4 position of 3-acylaminoazetidinones and products and starting materials therefor |
US4771135A (en) * | 1984-05-22 | 1988-09-13 | Eli Lilly And Company | Process for carbon-carbon bond formation at the C-4 position of 3-acylaminoazetidinones and products and starting materials therefor |
US4883869A (en) * | 1984-12-20 | 1989-11-28 | The Upjohn Company | Novel beta-lactams containing amino acid substituents |
US4824537A (en) * | 1985-02-06 | 1989-04-25 | Rikagaku Kenkyusho | Working substances used in laser isotope separation and method of laser isotope separation |
US5006650A (en) * | 1987-02-11 | 1991-04-09 | The Upjohn Company | Novel N-1 substituted beta-lactams as antibiotics |
KR890700586A (ko) * | 1987-02-27 | 1989-04-25 | 로버어트 에이 아마테이지 | 피리돈 카르복실산 또는 산유도체를 함유하는 항균제 베타-락탐 |
CA1317298C (fr) * | 1987-03-03 | 1993-05-04 | Upjohn Company (The) | .beta.-lactames antibiotiques activees par des groupes sulfonylaminocar bonyles |
US5015737A (en) * | 1987-07-22 | 1991-05-14 | The Upjohn Company | Therapeutically useful beta-lactams |
US4885362A (en) * | 1988-06-06 | 1989-12-05 | Eli Lilly And Company | Azetidinone intermediates for 1-carba(dethia)caphalosporins |
US5491139A (en) * | 1988-10-24 | 1996-02-13 | The Procter & Gamble Company | Antimicrobial quinolonyl lactams |
US5180719A (en) * | 1988-10-24 | 1993-01-19 | Norwich Eaton Pharmaceuticals, Inc. | Antimicrobial quinolonyl lactam esters |
EP0997466A1 (fr) * | 1988-10-24 | 2000-05-03 | PROCTER & GAMBLE PHARMACEUTICALS, INC. | Lactam-quinolones antimicrobiennes |
US5273973A (en) * | 1988-10-24 | 1993-12-28 | Norwich Eaton Pharmaceuticals, Inc. | Antimicrobial quinolonyl esters |
US5328908A (en) * | 1988-10-24 | 1994-07-12 | Procter & Gamble Pharmaceuticals, Inc. | Antimicrobial quinolone thioureas |
CA2001203C (fr) * | 1988-10-24 | 2001-02-13 | Thomas P. Demuth, Jr. | Dithiocarbamoyl quinolones antimicrobiens |
US5093029A (en) * | 1989-08-11 | 1992-03-03 | Atochem North America, Inc. | Breaking emulsions of alkanesulfonyl chlorides in aqueous hydrochloric acid |
ES2147721T3 (es) * | 1990-04-18 | 2000-10-01 | Procter & Gamble Pharma | Quinolonil lactamas antimicrobianas. |
US5478846A (en) * | 1990-06-07 | 1995-12-26 | Merrell Dow Pharmaceuticals Inc. | 1-piperidinyl alkanoylanyl sulfonamides for treatment of cardiac arrhythmia |
JP3032294B2 (ja) * | 1990-06-07 | 2000-04-10 | メレルダウファーマス―ティカルズ インコーポレイテッド | 1―ピペリジニルアルカノイルアリールスルホンアミド誘導体類 |
ES2049638B1 (es) * | 1992-05-13 | 1994-12-16 | Univ Pais Vasco | Procedimiento para la preparacion de compuestos beta-lactamicos homoquirales. |
DE69610978D1 (de) * | 1995-03-31 | 2000-12-21 | Naeja Pharmaceutical Inc | 4-substituierte-3-peptidyl-azetidin-2-on-derivate als cystein-proteinase inhibitoren |
US5840733A (en) * | 1996-07-01 | 1998-11-24 | Redcell, Canada, Inc. | Methods and compositions for producing novel conjugates of thrombin inhibitors and endogenous carriers resulting in anti-thrombins with extended lifetimes |
CA2266639A1 (fr) * | 1996-09-23 | 1998-03-26 | Rajeshwar Singh | Derives d'azetidine-2-one disubstituee en 3,4 regulateurs de cysteine proteinase |
CA2433280C (fr) * | 2000-12-27 | 2010-09-21 | Salus Pharma, Inc. | Aztreonam inhalable destine au traitement et a la prevention d'infections bacteriennes pulmonaires |
US7138419B2 (en) * | 2000-12-27 | 2006-11-21 | Corus Pharma, Inc. | Process for manufacturing bulk solutions and a lyophilized pure α-aztreonam lysinate |
US7214364B2 (en) | 2000-12-27 | 2007-05-08 | Corus Pharma, Inc. | Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections |
WO2003011298A1 (fr) * | 2001-08-03 | 2003-02-13 | Chirologix Pharmaceuticals Inc. | Oxazinones antibacteriennes et procedes d'utilisation et de synthese de celles-ci |
WO2003018565A1 (fr) * | 2001-08-29 | 2003-03-06 | Chirologix Pharmaceuticals Inc. | Procede de synthese d'oxazinones |
US20050005101A1 (en) * | 2003-07-03 | 2005-01-06 | Yenduri Bhargava K. | Kernel cryptographic module signature verification system and method |
EP2200564B1 (fr) | 2007-10-11 | 2016-05-04 | The Regents of The University of California | Compositions et procédés d'inhibition de l'amidase acide d'hydrolyse de la n-acyléthanolamine |
WO2014144547A2 (fr) * | 2013-03-15 | 2014-09-18 | The Regents Of The University Of California | Dérivés d'amide d'inhibiteurs de l'amidase acide de n-acyléthanolamine à base de lactame |
WO2014144836A2 (fr) | 2013-03-15 | 2014-09-18 | The Regents Of The University Of California | Dérivés de carbamate d'inhibiteurs d'amidase acide de n-acyléthanolamine (naaa) à base de lactame |
PL3122745T3 (pl) * | 2014-03-24 | 2019-08-30 | Novartis Ag | Monobaktamowe związki organiczne do leczenia zakażeń bakteryjnych |
JP6837480B2 (ja) | 2015-09-23 | 2021-03-03 | ノバルティス アーゲー | モノバクタム抗生物質の塩および固体形態 |
EP3661933B1 (fr) | 2017-08-02 | 2022-03-23 | Novartis AG | Procédé pour la préparation de 1-(((z)-(1-(2-aminothiazol-4-yl)-2-oxo-2-(((3s,4r)-2-oxo-4-((2-oxooxazolidin-3-yl)méthyl)-1-sulfoazétidin-3- yl)amino)éthylidene)amino)oxy)cyclopropane acide carboxylique |
CN112225720A (zh) * | 2020-11-10 | 2021-01-15 | 吴仁涛 | 一种噻吩-2-乙酰氯的生产方法 |
CN112480024A (zh) * | 2020-12-11 | 2021-03-12 | 山东金城医药化工有限公司 | 生产氨噻肟酸反式异构体的方法 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4200572A (en) * | 1975-09-03 | 1980-04-29 | Smithkline Corporation | Substituted azetidinones |
JPS6046955B2 (ja) * | 1977-12-30 | 1985-10-18 | 武田薬品工業株式会社 | 抗生物質g−6302 |
JPS5549394A (en) * | 1978-10-03 | 1980-04-09 | Takeda Chem Ind Ltd | Antibiotic substance sb-72310 |
US4260627A (en) * | 1978-10-24 | 1981-04-07 | Merck & Co., Inc. | 1-, 6- And 2-substituted-1-carba-2-penem-3-carboxylic acids |
DE3069587D1 (en) * | 1979-06-08 | 1984-12-13 | Takeda Chemical Industries Ltd | 1-sulpho-2-oxoazetidine derivatives, their production and pharmaceutical compositions thereof |
CA1242188A (fr) * | 1979-06-08 | 1988-09-20 | Takeda Pharmaceutical Company Limited | Derives de 3-methoxy-2-oxoazetidine et leur preparation |
JPS55164672A (en) * | 1979-06-08 | 1980-12-22 | Takeda Chem Ind Ltd | Azetidine derivative and its preparation |
NZ196202A (en) * | 1980-02-07 | 1984-07-31 | Squibb & Sons Inc | Beta-lactam antibiotics (of azetidine-sulphonic acid type) |
RO86528B (ro) * | 1980-02-07 | 1985-04-01 | E.R. Squibb And Sons Inc. | Procedeu pentru prepararea unor lactame |
EP0048953B1 (fr) * | 1980-09-29 | 1988-03-09 | E.R. Squibb & Sons, Inc. | Antibiotiques de bêta-lactame |
WO1982001873A1 (fr) * | 1980-12-05 | 1982-06-10 | Takeda Chemical Industries Ltd | Derives 1-sulfo-2-oxoazetidine et leur procede de preparation |
CA1181075A (fr) * | 1981-07-13 | 1985-01-15 | David M. Floyd | FORME CRISTALLISEE ANHYDRE DE L'ACIDE[3-S-[.alpha. (Z),4.beta.]]-3-[[(2-AMINO-4-THIAZOLYL) [(1-CARBOXY-1-METHYLETHOXY)IMINO]ACETYL]AMINO ]-4-METHYL-2-OXO-1-AZETIDINESULFONIQUE |
FR2515182B1 (fr) * | 1981-10-23 | 1986-05-09 | Roussel Uclaf | Nouveaux produits derives de l'acide 3-amino 2-oxo azetidine 1-sulfamique, leur procede de preparation, leur application comme medicaments et les produits intermediaires necessaires a leur preparation |
US4502994A (en) * | 1982-12-09 | 1985-03-05 | Hoffmann-La Roche Inc. | Enantiomeric synthesis of 3-amino-4-carbamoyloxymethyl-2-azetidonone-1-sulfate |
US4501697A (en) * | 1983-06-17 | 1985-02-26 | E. R. Squibb & Sons, Inc. | 4-[[(Amidomethyl)oxy]methyl]-2-oxo-1-azetidinesulfonic acid salts |
-
1980
- 1980-12-05 WO PCT/JP1980/000297 patent/WO1982001873A1/fr unknown
-
1981
- 1981-04-30 WO PCT/JP1981/000103 patent/WO1982003859A1/fr unknown
- 1981-08-21 WO PCT/JP1981/000183 patent/WO1983000689A1/fr unknown
- 1981-09-24 WO PCT/JP1981/000252 patent/WO1983001063A1/fr unknown
- 1981-11-19 IL IL64315A patent/IL64315A/xx unknown
- 1981-11-25 AU AU77829/81A patent/AU557689B2/en not_active Ceased
- 1981-12-02 YU YU2810/81A patent/YU43051B/xx unknown
- 1981-12-02 FI FI813852A patent/FI81085C/fi not_active IP Right Cessation
- 1981-12-02 DK DK534481A patent/DK534481A/da not_active Application Discontinuation
- 1981-12-02 NO NO814112A patent/NO160577C/no unknown
- 1981-12-03 US US06/326,937 patent/US4550105A/en not_active Expired - Fee Related
- 1981-12-03 US US06/326,938 patent/US4822788A/en not_active Expired - Fee Related
- 1981-12-03 BR BR8107866A patent/BR8107866A/pt unknown
- 1981-12-04 GR GR66689A patent/GR77295B/el unknown
- 1981-12-04 DE DE19813148021 patent/DE3148021A1/de not_active Withdrawn
- 1981-12-04 DE DE8181110155T patent/DE3176731D1/de not_active Expired
- 1981-12-04 GB GB8136619A patent/GB2091724B/en not_active Expired
- 1981-12-04 EP EP81110155A patent/EP0053816B1/fr not_active Expired
- 1981-12-04 BE BE206752A patent/BE891366A/fr not_active IP Right Cessation
- 1981-12-04 SE SE8107274A patent/SE457256B/sv not_active IP Right Cessation
- 1981-12-04 AT AT0520881A patent/AT378768B/de not_active IP Right Cessation
- 1981-12-04 NZ NZ199167A patent/NZ199167A/en unknown
- 1981-12-04 IT IT25464/81A patent/IT1139919B/it active
- 1981-12-04 IE IE2860/81A patent/IE53314B1/en unknown
- 1981-12-04 ES ES507715A patent/ES507715A0/es active Granted
- 1981-12-04 FR FR8122775A patent/FR2495613B1/fr not_active Expired
- 1981-12-04 PT PT74088A patent/PT74088B/pt unknown
- 1981-12-04 NL NL8105470A patent/NL8105470A/nl not_active Application Discontinuation
- 1981-12-04 LU LU83819A patent/LU83819A1/fr unknown
- 1981-12-04 CH CH7787/81A patent/CH657610A5/de not_active IP Right Cessation
- 1981-12-05 WO PCT/JP1981/000369 patent/WO1982002043A1/fr unknown
- 1981-12-07 PH PH26590A patent/PH25221A/en unknown
-
1982
- 1982-10-06 ES ES516254A patent/ES8400400A1/es not_active Expired
-
1983
- 1983-05-19 AR AR293082A patent/AR240171A1/es active
- 1983-06-30 YU YU01429/83A patent/YU142983A/xx unknown
-
1985
- 1985-06-05 US US06/741,741 patent/US4665067A/en not_active Expired - Fee Related
-
1987
- 1987-12-30 MY MY314/87A patent/MY8700314A/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LU83819A1 (fr) | Derives 1-sulfo-2-oxoazetidine,leur procede de preparation et leur utilisation dans des compositions anti-microbiennes | |
BE891607A (fr) | Derives de triazoline, leur procede de preparation et leur utilisation | |
FR2515645B1 (fr) | Derives de la proline optiquement actifs, procede pour leur preparation et leur application | |
BE873447A (fr) | Derives de 1,2,4-oxadiazole, leur procede de preparation et leur utilisation | |
BE890157A (fr) | Amino-polyols modifies, leur procede de preparation et leur utilisation | |
BE866031A (fr) | Nouveaux 2-(2,2-diarylalkyl)-1-azabicyclo (2,2,2)octanes, utiles notamment comme antidiarrheiques, et leur procede de preparation | |
BE895760A (fr) | Engrais, leur procede de preparation et leur utilisation | |
FR2485392B1 (fr) | Composes tensio-actifs cationiques, leur procede de preparation et leur utilisation cosmetique | |
BE869074A (fr) | Diurethannes, leur procede de preparation et leur utilisation | |
BE884286A (fr) | Acylurees, leur procede de preparation et leur utilisation | |
BE865805A (fr) | 1,2,3-thiadiazol-3-in-5-ylidene-urees, leur procede de preparation et leur utilisation | |
BE869605A (fr) | Nouveaux derives de la diphenoxy-1,3 propanone-2, procede pour leur preparation et leur utilisation dans des compositions pharmaceutiques | |
BE883348A (fr) | Thiazolylidene-oxo-propionitriles, leur procede de preparation et leur utilisation | |
BE855236A (fr) | Derives omega-nor-aromatiques de 13,14-dehydro-prostaglandines et procede pour leur preparation | |
FR2539126B1 (fr) | Derives amino-alcoyl-sulfoniques, leur procede de preparation, et compositions pharmaceutiques en renfermant | |
FR2463148B1 (fr) | Phenoxyalcoyl alcoxysilanes substitues et leur procede de preparation | |
RO81180A (fr) | Composition herbicide en forme de solution | |
BE877814A (fr) | Colorants oxaziniques cationiques, leur procede de preparation et leur utilisation | |
MA19907A1 (fr) | Procede de preparation de derives de la thiatriazine et utilisation de ceux-ci dans des compositions pharmaceutiques. | |
FR2534577B1 (fr) | Naphtalenecarboxamides, leur procede de preparation et leur utilisation | |
BE863402A (fr) | Azacycloalcanes, azacycloalcenes et derives de ceux-ci, leur procede de preparation et leur application en therapeutique | |
BE890390A (fr) | Derives de prostacycline, leur procede de preparation et leur utilisation | |
BE871647A (fr) | Colorants, leur procede de preparation et leur utilisation | |
BE854237A (fr) | 1,2,3-thiadiazol-5-yl-urees, leur procede de preparation et leur utilisation | |
BE890612A (fr) | Alkyl-3-aryl-3-acyl-2-methyl-carbazates, leur procede de preparation et leur utilisation fongicide |